StockData
ADRXNasdaqPharmaceutical PreparationsFiscal year ends December 31

ADARx Pharmaceuticals, Inc.

$17.63−0.02 (-0.11%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

ADARx Pharmaceuticals, Inc. revenue by segment

No segment breakdown reported

ADARx Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.